4
Changes in Ownership
Foghorn Therapeutics Inc. Filed Acc 0000899243-21-003967
Options or other derivatives
- Chief Financial Officer acquired 120,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Reine Allan Chief Financial Officer | 2021-01-28 | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | D | ||
Loading xslF345X03/doc4.xml…